Wed 12/12/2018 20:27 ET
S&P 5002651.0714.320.54%BANKS404.251.410.35%OIL51.380.180.35%BITCOIN3439.9345.061.31%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Hot Shots (VERSARTIS, INC - VSAR)    Market Movement, Emerging Markets, Commodities, Options

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add VSAR
From: Letstrade (Rep: 199)Date: 11/14/2017 10:23
Forum: Wall Street Hot Shots - Msg #24456 - List VSAR msgs Thread #673966048 (Rec: 0)
VSAR DD The 12-month HV for PP patients receiving somavaratan twice monthly was 9.71 cm, versus 10.63 cm for those receiving Genotropin daily. So They was giving there drug 2 times a month VS the other drug that was given Daily

The results are pretty close BUT yeah other drug was given daily vs VSAR Drug that was only given 2 times a month the drug clearly works

The company should have done additional study arms like

drug given every week

drug given 2 times a week

instead of just a single study given every 2 weeks

they also could have done different dosing in the study to see what dose and timing achieved the best results

i just think that the company did a poor job of doing this study

i think that if they did a more complete complex study they could have found a dose and timing that would have met or achieved the companies goals

not writting this one off yet as analyst projected sales at over 1 Billion Dollars if the drug worked

given the chart and news I think that the stock is a Buy down here trading way under cash and the drug clearly works just needs more studys done to find the right dosing and timing of giving the drug to patiences

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Letstrade: Reward | Watch | IgnoreVSAR: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add VSAR | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.